The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

A key part of consultants’ work is the global harmonization of CMC guidelines. Differences in regulatory requirements across regions can lead to inefficiencies in the drug development process.

DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

The partnership between Nvidia and Eli Lilly is not just about financial investment; it represents a new blueprint for how drugs will be developed in the future. By combining their resources and ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade later that the FDA approved Protropin, a ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Government regulations affect drug development, often prolonging the process, but they ensure safety and efficacy to protect ...